Hepatitis B Immunization Lab Testing
The recommended lab test after hepatitis B immunization to verify protective antibodies is anti-HBs (antibodies to hepatitis B surface antigen), which should be performed 1-2 months after completing the vaccination series using a quantitative method that can detect protective levels ≥10 mIU/mL. 1
Who Should Receive Post-Vaccination Testing
Post-vaccination serologic testing is not recommended for everyone but is specifically indicated for:
- Healthcare personnel and public safety workers at risk for blood exposure
- Hemodialysis patients and other persons requiring outpatient hemodialysis
- HIV-infected persons and other immunocompromised individuals
- Sex partners of HBsAg-positive persons
- Infants born to HBsAg-positive mothers 1, 2
Timing of Testing
Testing should be performed 1-2 months after administration of the final dose of the vaccine series. This timing is critical as it allows for accurate assessment of the immune response to vaccination. 1
Interpretation of Results
- Anti-HBs ≥10 mIU/mL: Considered protective and indicates immunity
- Anti-HBs <10 mIU/mL: Indicates lack of protective immunity 1
Management Based on Test Results
For those with anti-HBs ≥10 mIU/mL:
- Considered immune with long-term protection
- Immunocompetent persons do not need further periodic testing
- Immunocompromised persons may need annual testing to assess antibody levels 1
For those with anti-HBs <10 mIU/mL:
- Administer one additional dose of hepatitis B vaccine
- Retest anti-HBs 1-2 months later
- If still <10 mIU/mL, complete a second 3-dose series
- Test anti-HBs 1-2 months after final dose
- If still <10 mIU/mL after revaccination, test for HBsAg 1
Important Considerations
- Different assays have different cutoff values, so refer to the package insert of the test for accurate interpretation 1
- For persons who received HBIG (hepatitis B immune globulin) for post-exposure prophylaxis, testing should be delayed until 4-6 months after administration when anti-HBs from HBIG is no longer detectable 1
- Quantitative methods that can detect the protective threshold of ≥10 mIU/mL should be used rather than qualitative methods 2
Common Pitfalls to Avoid
Inappropriate timing of testing: Testing too early or too late may not accurately reflect vaccine-induced immunity 1
Using qualitative instead of quantitative testing: Only quantitative testing can confirm if protective levels (≥10 mIU/mL) have been achieved 2
Misinterpreting transient HBsAg positivity: Rarely, recently vaccinated individuals may test positive for HBsAg 1-3 days after vaccination, which does not indicate infection 3
Assuming immunity without testing high-risk groups: Studies have shown that up to 29% of vaccinated healthcare workers may not have serologic evidence of immunity when tested years after vaccination 4
Failing to test after revaccination: Individuals who did not respond to the initial series should be tested after completing the second series to document their immune status 1